Towards personalized treatment for early stage HER2-positive breast cancer | Nature Reviews Clinical Oncology
Clinical relevance of host immunity in breast cancer: from TILs to the clinic | Nature Reviews Clinical Oncology
Breast cancer | Nature Reviews Disease Primers
Upholding a role for EMT in breast cancer metastasis | Nature
Inflammatory breast cancer biology: the tumour microenvironment is key | Nature Reviews Cancer
A role for chromatin regulatory dynamics in breast cancer evolution | Nature Medicine
Breast cancer | Nature Reviews Disease Primers
Biological determinants of endocrine resistance in breast cancer | Nature Reviews Cancer
Spatial maps of genetically diverse breast cancer cells
Modelling breast cancer: one size does not fit all | Nature Reviews Cancer
Precision medicine for metastatic breast cancer—limitations and solutions | Nature Reviews Clinical Oncology
Breast cancer metastasis: markers and models | Nature Reviews Cancer
Breast cancer metastasis: markers and models | Nature Reviews Cancer
LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis | Nature Communications
Inflammatory breast cancer biology: the tumour microenvironment is key | Nature Reviews Cancer
Key steps for effective breast cancer prevention | Nature Reviews Cancer
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs | Nature Reviews Clinical Oncology
Origins of breast cancer subtypes and therapeutic implications | Nature Reviews Clinical Oncology
Breast cancer | Nature Reviews Disease Primers
Emerging targeted agents in metastatic breast cancer | Nature Reviews Clinical Oncology
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway | Nature
Breast cancer quantitative proteome and proteogenomic landscape | Nature Communications
Breast cancer | Nature Reviews Disease Primers
Chromatin regulators mediate anthracycline sensitivity in breast cancer | Nature Medicine
Breast cancer | Nature Reviews Disease Primers
